couter

IMDXInsight Molecular Diagnostics Inc.

Health CareBiotechnology
Oct 15, 2026 — Strategic Financing or Secondary Offering Announcement
Chart by TradingView

The schedule

  • Thu15Oct

    Expected announcement of a capital raise or debt restructuring to extend the critical cash runway ahead of Q3 reporting.

  • Mon9Nov

    Quarterly earnings print evaluating whether Q3 operations curbed the severe -53.8% YoY revenue contraction.

  • Tue12Jan

    Anticipated update on out-licensing proprietary diagnostic technology to a larger commercial partner.

  • Sun14Feb

    Year-end earnings and critical initial 2027 revenue guidance.

  • Wed12May

    Q1 update assessing early 2027 commercial traction and cash burn efficiency.

  • Mon9Aug

    Mid-year check-in on revenue run-rates and potential break-even targets.